全文获取类型
收费全文 | 101128篇 |
免费 | 6215篇 |
国内免费 | 437篇 |
专业分类
耳鼻咽喉 | 1134篇 |
儿科学 | 2520篇 |
妇产科学 | 1798篇 |
基础医学 | 12513篇 |
口腔科学 | 1758篇 |
临床医学 | 10726篇 |
内科学 | 20385篇 |
皮肤病学 | 1341篇 |
神经病学 | 10154篇 |
特种医学 | 3913篇 |
外国民族医学 | 3篇 |
外科学 | 16379篇 |
综合类 | 1085篇 |
一般理论 | 131篇 |
预防医学 | 8282篇 |
眼科学 | 2094篇 |
药学 | 6526篇 |
13篇 | |
中国医学 | 106篇 |
肿瘤学 | 6919篇 |
出版年
2024年 | 174篇 |
2023年 | 614篇 |
2022年 | 972篇 |
2021年 | 2151篇 |
2020年 | 1388篇 |
2019年 | 2101篇 |
2018年 | 2555篇 |
2017年 | 1825篇 |
2016年 | 1988篇 |
2015年 | 2279篇 |
2014年 | 3450篇 |
2013年 | 4733篇 |
2012年 | 7569篇 |
2011年 | 7983篇 |
2010年 | 4586篇 |
2009年 | 4135篇 |
2008年 | 7135篇 |
2007年 | 7459篇 |
2006年 | 7185篇 |
2005年 | 6902篇 |
2004年 | 6720篇 |
2003年 | 6055篇 |
2002年 | 5711篇 |
2001年 | 849篇 |
2000年 | 563篇 |
1999年 | 894篇 |
1998年 | 1221篇 |
1997年 | 929篇 |
1996年 | 752篇 |
1995年 | 686篇 |
1994年 | 590篇 |
1993年 | 587篇 |
1992年 | 455篇 |
1991年 | 409篇 |
1990年 | 333篇 |
1989年 | 300篇 |
1988年 | 282篇 |
1987年 | 283篇 |
1986年 | 244篇 |
1985年 | 283篇 |
1984年 | 308篇 |
1983年 | 255篇 |
1982年 | 337篇 |
1981年 | 282篇 |
1980年 | 222篇 |
1979年 | 94篇 |
1978年 | 130篇 |
1977年 | 106篇 |
1976年 | 82篇 |
1973年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
Bo Feng Angela C. Doran Li Di Mark A. West Sarah M. Osgood Jessica Y. Mancuso Christopher L. Shaffer Larry Tremaine Jennifer Liras 《Journal of pharmaceutical sciences》2018,107(8):2225-2235
Four P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) substrates with human cerebrospinal fluid (CSF) concentrations and preclinical neuropharmacokinetics were used to assess in vitro–in vivo extrapolation of brain penetration in preclinical species and the ability to predict human brain penetration. Unbound brain (Cb,u), unbound plasma (Cp,u), and CSF compound concentrations (CCSF) were measured in rats and nonhuman primates (NHPs), and the unbound partition coefficients (Cb,u/Cp,u and CCSF/Cp,u) were used to assess brain penetration. The results indicated that for P-gp and BCRP dual substrates, brain penetration was severally impaired in all species. In comparison, for P-gp substrates that are weak or non-BCRP substrates, improved brain penetration was observed in NHPs and humans than in rats. Overall, NHP appears to be more predictive of human brain penetration for P-gp substrates with weak or no interaction with BCRP than rat. Although CCSF does not quantitatively correspond to Cb,u for efflux transporter substrates, it is mostly within 3-fold higher of Cb,u in rat and NHP, suggesting that CCSF can be used as a surrogate for Cb,u. Taken together, a holistic approach including both in vitro transporter and in vivo neuropharmacokinetics data enables a better estimation of human brain penetration of P-gp/BCRP substrates. 相似文献
12.
13.
Wilberforce Mark Challis David Davies Linda Kelly Michael P. Roberts Chris 《Quality of life research》2018,27(10):2745-2756
Quality of Life Research - Researchers investigating person-centredness in older people’s long-term community care are hindered by the lack of appropriate measures. Studies have tended to... 相似文献
14.
15.
16.
Medellena Maria Glymour Adam Mark Brickman Mika Kivimaki Elizabeth Rose Mayeda Geneviève Chêne Carole Dufouil Jennifer Jaie Manly 《European journal of epidemiology》2018,33(7):607-612
A recently published framework for the diagnosis of Alzheimer’s disease (AD) in research studies would allow diagnosis on the sole basis of two biomarkers (β-amyloid and pathologic tau), even in people with no objective or subjective memory or cognitive changes. This revision will have substantial implications for future Alzheimer’s research, and the changes should be rigorously evaluated before widespread adoption. We propose three principles for evaluating any revision to diagnostic frameworks for AD: (1) does the revision improve the validity of the diagnosis; (2) does the revision improve the reliability or reduce the expense of the diagnosis; and (3) will the revision foster innovative and rigorous research across populations. The new diagnostic framework is unlikely to achieve any of these goals. Instead, it has the potential to handicap future researchers, and slow progress towards identifying effective strategies to prevent or treat AD. 相似文献
17.
18.
Inga Koneczny Dorit Rennspiess Florit Marcuse Nathalie Dankerlui Myurgia Abdul Hamid Marina Mané-Damas Jos Maessen Paul Van Schil Abhishek Saxena Paraskevi Zisimopoulou Konstantinos Lazaridis Mark Woodhall Katerina Karagiorgou John Tzartos Socrates Tzartos Marc H. De Baets Peter C. Molenaar Alexander Marx Pilar Martinez-Martinez 《Autoimmunity reviews》2019,18(1):50-55
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction. Most patients have pathogenic autoantibodies against the acetylcholine receptor (AChR). In the last years a novel subpopulation of MG patients has been described that harbors antibodies against low-density lipoprotein receptor-related protein 4 (Lrp4), another postsynaptic neuromuscular antigen. In early-onset AChR MG (EOMG), the thymus plays an important role in immunopathogenesis, and early thymectomy is beneficial. It is still unknown if the thymus plays any role in Lrp4-MG. In this pilot study, we compared thymus samples from four patients with Lrp4-MG (one pre-treated with immunosuppressive drugs), four non-MG controls and five EOMG patients (not pretreated with immunosuppressive drugs). Immunohistochemistry of the Lrp4-MG thymi revealed normal architecture, with normal numbers and distribution of B-cells, lymphoid follicles and Hassall's corpuscles. Primary CD23+ lymphoid follicles were similarly infrequent in Lrp4-MG and control thymic sections. In none of the control or Lrp4-MG thymi did we find secondary follicles with CD10+ germinal centers. These were evident in 2 of the 5 EOMG thymi, where primary lymphoid follicles were also more frequent on average, thus showing considerable heterogeneity between patients. Even if characteristic pathological thymic changes were not observed in the Lrp4 subgroup, we cannot exclude a role for the thymus in Lrp4-MG pathogenesis, since one Lrp4-MG patient went into clinical remission after thymectomy alone (at one year follow-up) and one more improved after thymectomy in combination with immunosuppressive therapy. 相似文献
19.
20.
James Kerns Hristo Piponov Cory Helder Farid Amirouche Giovanni Solitro Mark Gonzalez 《Anatomical record (Hoboken, N.J. : 2007)》2019,302(11):2030-2039
Despite the extensive literature regarding peripheral nerve stretch injuries, there are few studies that compare the nerve histology with the mechanical properties in humans. There is clinical evidence suggesting that the peroneal nerve is at greater risk for injury compared to the tibial nerve following total hip arthroplasty and hip trauma. We examined the two nerves from fresh human cadavers with or without controlled stretch. The mechanical properties, stiffness, and strain were compared with light microscopic preparations in longitudinal sections stained by the trichrome method for collagen and showing the effects of structural deformation. The tibial nerve had an average failure load 1.7× that for the peroneal nerve (P = 0.0001). Although the corresponding average stiffness showed a trend toward being larger (4.39 vs. 3.81 N/mm), the difference was not significant (P = 0.126). Histologically, the perineurium along with the underlying nerve fascicle was undulated in the control specimens and straightened out in the stretched specimens. Peroneal nerves went on to failure at lower loads and exhibited a wavy pattern on pathologic slides after failure, which shows that peroneal nerves fail mechanically before they can unfold. The tibial nerve has a biomechanical and histological advantage compared to the peroneal nerve during tensile testing, which could be the reason why it is less commonly damaged. We conclude that the perineurium is especially protective against deformation changes in human nerves relative to the respective nerve size and number of fascicles. Anat Rec, 302:2030–2039, 2019. © 2019 American Association for Anatomy 相似文献